Citation Impact

Citing Papers

American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy
2018
Tumour-cell invasion and migration: diversity and escape mechanisms
2003 Standout
Spanish Consensus Statement on alternatives to allogeneic blood transfusion: the 2013 update of the "Seville Document".
2013
Assays of different aspects of haemostasis – what do they measure?
2015 StandoutNobel
Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas
1999
A manifesto for reproducible science
2017 Standout
Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic
2020 Standout
“It feels like I’m the dirtiest person in the world.”
2017
Early and individualized goal-directed therapy for trauma-induced coagulopathy
2012
Preparation of cryoprecipitate from riboflavin and UV light-treated plasma
2012
Potentiation of NK cell-mediated cytotoxicity in human lung adenocarcinoma: role of NKG2D-dependent pathway
2008
Matrix metalloproteinases and the regulation of tissue remodelling
2007 Standout
International Union of Pharmacology. XLIX. Nomenclature and Structure-Function Relationships of Transient Receptor Potential Channels
2005 StandoutNobel
Stromal fibroblasts in cancer initiation and progression
2004 StandoutNature
Fixed ratio versus goal-directed therapy in trauma
2015
Tissue Inhibitor of Matrix Metalloproteinase-2 Regulates Matrix Metalloproteinase-2 Activation by Modulation of Membrane-type 1 Matrix Metalloproteinase Activity in High and Low Invasive Melanoma Cell Lines
1999
Oxidative stress, inflammation, and cancer: How are they linked?
2010 Standout
Patient Blood Management Bundles to Facilitate Implementation
2016
Cancer to bone: a fatal attraction
2011 Standout
The exclusive use of coagulation factor concentrates enables reversal of coagulopathy and decreases transfusion rates in patients with major blunt trauma
2012
Doctors in society: medical professionalism in a changing world
2006
Melanin Pigmentation in Mammalian Skin and Its Hormonal Regulation
2004 Standout
Development of Matrix Metalloproteinase Inhibitors in Cancer Therapy
2001
Trauma-associated bleeding
2016
Early cryoprecipitate for major haemorrhage in trauma: a randomised controlled feasibility trial
2015
Expression and Up-Regulation of Alternatively Spliced Transcripts of Melastatin, a Melanoma Metastasis-Related Gene, in Human Melanoma Cells
2000
Targeted Thromboelastographic (TEG) Blood Component and Pharmacologic Hemostatic Therapy in Traumatic and Acquired Coagulopathy
2016
The role of NFAT transcription factors in integrin-mediated carcinoma invasion
2002 Standout
Transfusion Interventions in Critical Bleeding Requiring Massive Transfusion: A Systematic Review
2015
Adverse effects of plasma transfusion
2012
Fibrinogen concentrates for bleeding trauma patients: what is the evidence?
2011
Molecularly targeted agents: Their promise as cancer chemopreventive interventions
2005
Putting tumours in context
2001 Standout
Practice management of acute trauma haemorrhage and haemostatic disorders across German trauma centres
2015
Haematological problems in obstetrics
2015
Matrix Metalloproteinase 9 Promoter Activity Is Induced Coincident with Invasion during Tumor Progression
2000
Apigenin: A Promising Molecule for Cancer Prevention
2010 Standout
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
2010 Standout
Massive Bleeding and Massive Transfusion
2012
Transfusion reactions: prevention, diagnosis, and treatment
2016
Physiological changes in pregnancy
2016 Standout
The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis
2001
Cryoprecipitate use in the PROMMTT study
2013
Damage control resuscitation in patients with severe traumatic hemorrhage
2016
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
2016 Standout
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
2015 Standout
Matrix Metalloproteinases in Human Melanoma
2000
Reactive oxygen species in cancer
2010 Standout
Different Roles for Plasminogen Activators and Metalloproteinases in Melanoma Metastasis
1996
Prevalence of depression, anxiety, and insomnia among healthcare workers during the COVID-19 pandemic: A systematic review and meta-analysis
2020 Standout
Cytokine sensitivity of metastatic human melanoma cell lines -simultaneous inhibition of proliferation and enhancement of gelatinase activity
1998
An examination of the effects of hypoxia, acidosis, and glucose starvation on the expression of metastasis-associated genes in murine tumor cells
1997
Melanoma × macrophage hybrids with enhanced metastatic potential
1998
Microenvironmental regulation of metastasis
2008 Standout
Prehospital Resuscitation of Traumatic Hemorrhagic Shock with Hypertonic Solutions Worsens Hypocoagulation and Hyperfibrinolysis
2015
Imaging matrix metalloproteinases in cancer
2008
A systematic review shows no performance benefit of machine learning over logistic regression for clinical prediction models
2019 Standout
Complications of Allogeneic Blood Product Administration, with Emphasis on Transfusion-Related Acute Lung Injury and Transfusion-Associated Circulatory Overload
2017
Optimal Dose, Timing and Ratio of Blood Products in Massive Transfusion: Results from a Systematic Review
2017
Clotting Factor Deficiency in Early Trauma-Associated Coagulopathy
2011
Reduced mortality by meeting guideline criteria before using recombinant activated factor VII in severe trauma patients with massive bleeding
2016
Relation of completeness of reporting of health research to journals' endorsement of reporting guidelines: systematic review
2014
Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects
2001 Standout
Matrix metalloproteinases in tumor–host cell communication
2002
The impact of fresh frozen plasma vs coagulation factor concentrates on morbidity and mortality in trauma-associated haemorrhage and massive transfusion
2011
Health professionals for a new century: transforming education to strengthen health systems in an interdependent world
2010 Standout
Metastatic ability of Drosophila tumors depends on MMP activity
2006
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
2011 Standout
Thromboelastography in Orthopaedic Trauma Acute Pelvic Fracture Resuscitation
2016
Effect of coagulation factor concentrate administration on ROTEM® parameters in major trauma
2015
Quality of reporting of confounding remained suboptimal after the STROBE guideline
2015
New functions for the matrix metalloproteinases in cancer progression
2002 Standout
Risk Perception and Impact of Severe Acute Respiratory Syndrome (SARS) on Work and Personal Lives of Healthcare Workers in Singapore
2005
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Association of Cryoprecipitate and Tranexamic Acid With Improved Survival Following Wartime Injury
2012
Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy
2011
Effect of Plasma-to-RBC Ratios in Trauma Patients
2013
Mulberry anthocyanins, cyanidin 3-rutinoside and cyanidin 3-glucoside, exhibited an inhibitory effect on the migration and invasion of a human lung cancer cell line
2005 Standout
Curcumin: From ancient medicine to current clinical trials
2008 Standout
Matrix metalloproteinases and tumor metastasis
2006 Standout
Cumulative Influence of Matrix Metalloproteinase-1 and -2 in the Migration of Melanoma Cells within Three-Dimensional Type I Collagen Lattices
2001
Role of matrix metalloproteinases in melanoma cell invasion
2005
Reduction of Fresh Frozen Plasma Requirements by Perioperative Point-of-Care Coagulation Management with Early Calculated Goal-Directed Therapy
2012
Expression of matrix metalloproteinases in the microenvironment of spontaneous and experimental melanoma metastases reflects the requirements for tumor formation.
2003
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Matrix Metalloproteinases: Biologic Activity and Clinical Implications
2000
Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation
2009 Standout
NK CELL RECOGNITION
2004 Standout
Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion
2016 Standout
Management of bleeding and coagulopathy following major trauma: an updated European guideline
2013
How I use fibrinogen replacement therapy in acquired bleeding
2014
The Natural History of Trauma-Related Coagulopathy: Implications for Treatment
2011
How I treat patients with massive hemorrhage
2014
New Enzyme-Activated Solubility-Switchable Contrast Agent for Magnetic Resonance Imaging: From Synthesis to in Vivo Imaging
2009
Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinases-3 inhibits invasion and induces apoptosis in melanoma cells.
1998
Evasion from NK Cell Immunity by MHC Class I Chain-Related Molecules Expressing Colon Adenocarcinoma
2003
Low-dose recombinant factor VIIa for reversing coagulopathy in patients with isolated traumatic brain injury
2014
Initiation and Termination of Massive Transfusion Protocols: Current Strategies and Future Prospects
2017
The residual risk of transfusion‐related acute lung injury at the American Red Cross (2008‐2011): limitations of a predominantly male‐donor plasma mitigation strategy
2012
The antitumor activities of flavonoids.
2005 Standout
Controlling and Switching the Morphology of Micellar Nanoparticles with Enzymes
2011
Change of transfusion and treatment paradigm in major trauma patients
2017
Haemostatic profile of reconstituted blood in a proposed 1:1:1 ratio of packed red blood cells, platelet concentrate and four different plasma preparations
2015
International consensus statement on the peri‐operative management of anaemia and iron deficiency
2016 Standout
Cryoprecipitate administration after trauma
2015
Regulation of matrix metalloproteinase expression in tumor invasion
1999 Standout
New photosensitizers for photodynamic therapy
2016 Standout
COVID-19 and its implications for thrombosis and anticoagulation
2020 Standout
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
2002 StandoutScience
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
Indications and Risks of Fibrinogen in Surgery and Trauma
2015
Inhibition of matrix metalloproteinase 9 expression by a ribozyme blocks metastasis in a rat sarcoma model system.
1996
Coagulopathy induced by acidosis, hypothermia and hypocalcaemia in severe bleeding.
2015
How Matrix Metalloproteinases Regulate Cell Behavior
2001 Standout
Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer
2011 Standout
Systematic Review: Benefits and Harms of In-Hospital Use of Recombinant Factor VIIa for Off-Label Indications
2011
Management of traumatic haemorrhage – the European perspective
2014
Consenso colombiano de atención, diagnóstico y manejo de la infección por SARS-COV-2/COVID 19 en establecimientos de atención de la salud. Recomendaciones basadas en consenso de expertos e informadas en la evidencia
2020 Standout
Hematological findings and complications of COVID‐19
2020 Standout

Works of Yulia Lin being referenced

Internal medicine resident knowledge of transfusion medicine: results from the BESTTEST international education needs assessment
2014
The utility of recombinant factor VIIa as a last resort in trauma
2012
Transfusion‐related acute lung injury prevention measures and their impact at Canadian Blood Services
2011
‘Proteolytic switching’: opposite patterns of regulation of gelatinase B and its inhibitor TIMP-1 during human melanoma progression and consequences of gelatinase B overexpression
1999
Cryoprecipitate transfusion: assessing appropriateness and dosing in trauma
2011
A systematic assessment of the quality of reporting for platelet transfusion studies
2010
Clinical review: Fresh frozen plasma in massive bleedings - more questions than answers
2010
The Prevention of Transfusion-Associated Circulatory Overload
2013
Cryoprecipitate: The Current State of Knowledge
2009
Effect of a fixed-ratio (1:1:1) transfusion protocol versus laboratory-results–guided transfusion in patients with severe trauma: a randomized feasibility trial
2013
Severe acute respiratory syndrome and its impact on professionalism: qualitative study of physicians' behaviour during an emerging healthcare crisis
2004
Recombinant factor VIIA is associated with an improved 24-hour survival without an improvement in inpatient survival in massively transfused civilian trauma patients
2011
Perioperative transfusion-related acute lung injury: The Canadian Blood Services experience
2014
A Retrospective Review of Patient Factors, Transfusion Practices, and Outcomes in Patients With Transfusion-Associated Circulatory Overload
2013
Use of recombinant factor VIIa for the prevention and treatment of bleeding in patients without hemophilia: a systematic review and meta-analysis
2010
The 92-kDa gelatinase B is expressed by advanced stage melanoma cells: suppression by somatic cell hybridization with early stage melanoma cells.
1995
Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia
2012
Prothrombin Complex Concentrate for Major Bleeding on Factor Xa Inhibitors: A Prospective Cohort Study
2018
Rankless by CCL
2026